These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8254086)

  • 1. Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma.
    Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
    J Clin Pathol; 1993 Nov; 46(11):1009-10. PubMed ID: 8254086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining.
    Jensen ML; Kiaer H; Melsen F
    Histopathology; 1996 Sep; 29(3):241-5. PubMed ID: 8884352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of p53 protein expression in breast carcinomas.
    Hurlimann J
    Pathol Res Pract; 1993 Nov; 189(9):996-1003. PubMed ID: 8302733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine proteinase inhibitor cystatin A in breast cancer.
    Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
    Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scarff-bloom-richardson histoprognostic grading correlates with the immunohistochemical expressions of genomic alterations in infiltrating ductal carcinomas (nos) of the breast.
    Martinazzi M; Zampatti C; Crivelli F; Zampieri A; Martinazzi S
    Oncol Rep; 1994 Nov; 1(6):1087-91. PubMed ID: 21607496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients.
    Koutselini H; Markopoulos C; Lambropoulou S; Gogas H; Kandaraki C; Gogas J
    Cytopathology; 1995 Feb; 6(1):14-21. PubMed ID: 7734697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of cathepsin D, proliferating cell nuclear antigen and epidermal growth factor receptor in human breast carcinoma analysed by computer image analyser: correlation with histological grade and metastatic behaviour.
    Okamura K; Kobayashi I; Matsuo K; Kiyoshima T; Yamamoto K; Miyoshi A; Sakai H
    Histopathology; 1997 Dec; 31(6):540-8. PubMed ID: 9447385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
    Bedner E; Harezga B; Osborn M; Domagała W
    Pol J Pathol; 1995; 46(1):11-5. PubMed ID: 7780691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.
    Umekita Y; Enokizono N; Sagara Y; Kuriwaki K; Takasaki T; Yoshida A; Yoshida H
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):345-51. PubMed ID: 1348890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
    Looi LM; Cheah PL
    Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
    Moll R; Mitze M; Frixen UH; Birchmeier W
    Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin intermediate filament expression in benign and malignant breast disease.
    Heatley M; Maxwell P; Whiteside C; Toner P
    J Clin Pathol; 1995 Jan; 48(1):26-32. PubMed ID: 7535804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low, intermediate and high grade breast carcinomas as determined by histotyping, immunohistochemical prognosticators and histological grading.
    Martinazzi M; Crivelli F; Zampatti C; Pisani P
    Pathologica; 1992; 84(1089):33-47. PubMed ID: 1323096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between histological grade and c-erbB2 oncoprotein overexpression in infiltrating ductal carcinoma of breast.
    Looi LM; Cheah PL; Yap SF
    Malays J Pathol; 1997 Jun; 19(1):35-9. PubMed ID: 10879240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.
    Rosen PP; Lesser ML; Arroyo CD; Cranor M; Borgen P; Norton L
    J Clin Oncol; 1995 Apr; 13(4):821-30. PubMed ID: 7707107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin and beta-catenin expression in breast medullary carcinomas.
    Charpin C; Bonnier P; Garcia S; Andrac L; Crebassa B; Dorel M; Lavaut MN; Allasia C
    Int J Oncol; 1999 Aug; 15(2):285-92. PubMed ID: 10402239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas.
    Turashvili G; Bouchal J; Burkadze G; Kolár Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):57-62. PubMed ID: 16170389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
    Qi CF; Liscia DS; Normanno N; Merlo G; Johnson GR; Gullick WJ; Ciardiello F; Saeki T; Brandt R; Kim N
    Br J Cancer; 1994 May; 69(5):903-10. PubMed ID: 8180021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.